For millions of individuals living with Type 2 Diabetes across the United States, United Kingdom, Germany, Japan, China, Canada, France, Netherlands, Switzerland, Australia, Dubai, Finland, and Austria, Metformin remains the gold-standard first-line treatment. By 2026, our understanding of this “old but marvelous” medication has evolved, revealing a multifaceted approach to metabolic health that goes far […]
For millions of individuals living with Type 2 Diabetes across the United States, United Kingdom, Germany, Japan, China, Canada, France, Netherlands, Switzerland, Australia, Dubai, Finland, and Austria, Metformin remains the gold-standard first-line treatment. By 2026, our understanding of this “old but marvelous” medication has evolved, revealing a multifaceted approach to metabolic health that goes far […]